Elicit vs AgingResearch.News
Choose Elicit for
Researchers running systematic reviews and evidence syntheses in any discipline: screening thousands of papers, extracting data into tables and exporting to reference managers.
Choose AgingResearch.News for
People who follow aging research and want each new paper read and judged as it appears, the important ones told in plain words, and the evidence on each drug, gene and process kept on one page.
Side by side
- What it is
- AgingResearch.News A reader of aging research: feeds, stories, evidence pages and Ask
- Elicit An AI research assistant1
- Papers
- AgingResearch.News New papers from PubMed, bioRxiv and medRxiv every 10 minutes; arXiv, other preprint servers and the journals PubMed misses within hours; papers in other languages translated, then judged.
- Elicit Over 138 million papers from Semantic Scholar, PubMed and OpenAlex, all disciplines, updated weekly; ClinicalTrials.gov2
- Systematic reviews
- AgingResearch.News None
- Elicit A systematic review workflow: screening up to 5,000 papers on Pro, 40,000 on Enterprise, with extraction tables1
- Full text
- AgingResearch.News Full text held for open papers; paywalled papers are read from their abstract.
- Elicit Full text when open access or through its browser extension and your subscription; else title and abstract2
- New papers
- AgingResearch.News Follow a drug, gene, author or search and get an email when a new paper lands (3 free, 25 with Plus). Plus builds For you from a sentence about your work.
- Elicit Routines, on Pro1
- Free
- AgingResearch.News Every feed, story and page without an account. A free account adds 3 questions a day to Ask, 3 follows with email and the Monday digest.
- Elicit Unlimited search, summaries and chat with papers; limited use of its research agent and reports1
- Price
- AgingResearch.News Free to read. Plus $12 a month or $99 a year; Pro, for company and pipeline intelligence, $59 a month.
- Elicit Billed yearly: academic $11, $39 and $89 a user a month; industry $49 and $1691
Where Elicit is stronger
- Its systematic review workflow screens thousands of papers and extracts data into tables, a job AgingResearch.News does not do.
- It covers all disciplines, with over 138 million papers and ClinicalTrials.gov.
- It extracts data from papers you upload, and on its Scale plan from figures, with live collaboration and an API.
- It exports to RIS, CSV, BIB, PDF and DOCX.
Where AgingResearch.News is different
- It reads new aging papers within minutes to hours of their appearing, and judges what each paper's own work shows about aging.
- The papers worth reading become short stories in plain words, each checked against its paper and naming its main limit.
- Each drug, gene and process has a page that shows where its evidence stands, with its trials, funders and company ties.
- Retracted papers leave every feed, email and answer.
- Reading is free, and Plus is priced for one person.
On AgingResearch.News now
On a typical day this past week, 4,500 new papers were read and 48 stories published, from a record of 821,293 papers.
- Alzheimer imaging dataset spans healthy aging and disease
Study in people · Oct 21, 2026
- Cell identity stayed intact in aging mouse brain cells
Preprint: experiments in animals · Oct 21, 2026
- Chemical changes mark aging in animal cell recycling centers
Experiments in animals · Oct 21, 2026
- Top
The day's most significant aging research, as stories
- Latest
Every paper that reached the feeds, newest first
- Ask AgingResearch.News
Questions answered from the papers, every claim cited
- Metformin
Its studies, trials and stage toward patients on one page
- Trials
Clinical trials judged for what they mean for aging
- Data API
Papers, stories, entities and trials for your own tools
Sources
Every fact about Elicit above is from its own pages, read on the date given.
- 1. Elicit: Pricing, read Oct 20, 2026
- 2. Elicit Help: Elicit's source for papers, read Oct 20, 2026